Press "Enter" to skip to content

Alisertib and romidepsin combination for aggressive R/R T-cell and B-cell lymphomas – Lymphoma Hub

admin 0

Alisertib and romidepsin combination for aggressive R/R T-cell and B-cell lymphomas  Lymphoma Hub

On 9 May 2019, Paolo Strati from the MD Anderson Cancer Center, Houston, TX, USA, and colleagues, published in Haematologica1 results from a phase I …

“lymphoma cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *